Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Lenschow

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|October 1, 1993
T cell co-stimulation and in vivo toleranceD J Lenschow, J A Bluestone
Annual Review of Immunology|January 1, 1996
CD28/B7 system of T cell costimulationD J Lenschow, T L Walunas, J A Bluestone
Immunologic Research|February 1, 1997
CD28/B7 regulation of autoimmune diabetesK G Herold, D J Lenschow, J A Bluestone
Digestive Diseases and Sciences|January 1, 1995
Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptorsM L Alegre, D J Lenschow, J A Bluestone
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2R M Stack, D J Lenschow, G S Gray, et al.
Immunity|May 5, 2000
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetesB Salomon, D J Lenschow, L Rhee, et al.
Journal of Neuroimmunology|December 12, 1997
Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAEC L Vanderlugt, N J Karandikar, D J Lenschow, et al.
The Journal of Experimental Medicine|March 1, 1995
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouseD J Lenschow, S C Ho, H Sattar, et al.
Science (New York, N.Y.)|August 7, 1992
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lgD J Lenschow, Y Zeng, J R Thistlethwaite, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
Expression and functional significance of an additional ligand for CTLA-4D J Lenschow, G H Su, L A Zuckerman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|October 1, 1993
T cell co-stimulation and in vivo toleranceD J Lenschow, J A Bluestone
Annual Review of Immunology|January 1, 1996
CD28/B7 system of T cell costimulationD J Lenschow, T L Walunas, J A Bluestone
Immunologic Research|February 1, 1997
CD28/B7 regulation of autoimmune diabetesK G Herold, D J Lenschow, J A Bluestone
Digestive Diseases and Sciences|January 1, 1995
Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptorsM L Alegre, D J Lenschow, J A Bluestone
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2R M Stack, D J Lenschow, G S Gray, et al.
Immunity|May 5, 2000
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetesB Salomon, D J Lenschow, L Rhee, et al.
Journal of Neuroimmunology|December 12, 1997
Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAEC L Vanderlugt, N J Karandikar, D J Lenschow, et al.
The Journal of Experimental Medicine|March 1, 1995
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouseD J Lenschow, S C Ho, H Sattar, et al.
Science (New York, N.Y.)|August 7, 1992
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lgD J Lenschow, Y Zeng, J R Thistlethwaite, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
Expression and functional significance of an additional ligand for CTLA-4D J Lenschow, G H Su, L A Zuckerman, et al.
Pageof 2